Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial
- PMID: 21246576
- PMCID: PMC3149858
- DOI: 10.1002/lsm.20984
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial
Abstract
Background: Photodynamic therapy (PDT) is a non-invasive treatment for non-melanoma skin cancer. However, PDT systems currently used clinically have limitations such as pain and superficial tissue penetration. The silicon phthalocyanine Pc 4 is a second-generation photosensitizer with peak absorption in the far red at 675 nm.
Objective: To assess the safety and tolerability of topically applied Pc 4 followed by red light (Pc 4-PDT) in treating cutaneous neoplasms.
Study design/materials and methods: Forty three adults with a diagnosis of neoplasms including actinic keratoses, Bowen's disease, squamous cell carcinoma, basal cell carcinoma, or mycosis fungoides were treated with a single administration of Pc 4-PDT and followed for 14 days. The study utilized a light and Pc 4 dose escalation design in sequential groups of three subjects each.
Results: Pc 4-PDT was well tolerated with no significant local toxicity or increased photosensitivity. It has promising biologic effects, particularly in mycosis fungoides where 14 of 35 subjects demonstrated a clinical response, which correlates with Pc 4-PDT-induced apoptosis, as measured by increased active caspase-3 in the treated skin lesions.
Conclusions: Pc 4-PDT is a safe and tolerable treatment modality that effectively triggers apoptosis in cutaneous neoplasms such as mycosis fungoides.
Copyright © 2010 Wiley-Liss, Inc.
Figures




Similar articles
-
Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.Photochem Photobiol. 1997 May;65(5):895-901. doi: 10.1111/j.1751-1097.1997.tb01940.x. Photochem Photobiol. 1997. PMID: 9155263
-
Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.Photochem Photobiol. 1999 Jul;70(1):72-7. Photochem Photobiol. 1999. PMID: 10420845
-
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.Clin Cancer Res. 2000 May;6(5):2021-7. Clin Cancer Res. 2000. PMID: 10815928
-
Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy.Am J Clin Dermatol. 2001;2(4):229-37. doi: 10.2165/00128071-200102040-00004. Am J Clin Dermatol. 2001. PMID: 11705250 Review.
-
European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.J Eur Acad Dermatol Venereol. 2013 May;27(5):536-44. doi: 10.1111/jdv.12031. Epub 2012 Nov 26. J Eur Acad Dermatol Venereol. 2013. PMID: 23181594 Review.
Cited by
-
Theranostics with photodynamic therapy for personalized medicine: to see and to treat.Theranostics. 2023 Oct 9;13(15):5501-5544. doi: 10.7150/thno.87363. eCollection 2023. Theranostics. 2023. PMID: 37908729 Free PMC article. Review.
-
Syntheses and Photodynamic Activity of Pegylated Cationic Zn(II)-Phthalocyanines in HEp2 Cells.Theranostics. 2012;2(9):850-70. doi: 10.7150/thno.4547. Epub 2012 Sep 20. Theranostics. 2012. PMID: 23082098 Free PMC article.
-
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents.Pharmaceuticals (Basel). 2021 Nov 12;14(11):1155. doi: 10.3390/ph14111155. Pharmaceuticals (Basel). 2021. PMID: 34832938 Free PMC article.
-
Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans.Photochem Photobiol. 2011 Jul-Aug;87(4):904-9. doi: 10.1111/j.1751-1097.2011.00938.x. Epub 2011 Jun 13. Photochem Photobiol. 2011. PMID: 21521233 Free PMC article.
-
The elements of life and medicines.Philos Trans A Math Phys Eng Sci. 2015 Mar 13;373(2037):20140182. doi: 10.1098/rsta.2014.0182. Philos Trans A Math Phys Eng Sci. 2015. PMID: 25666066 Free PMC article.
References
-
- Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA. Guidelines on the use of photodynamic therapy for nonmelanoma skin caner: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–143. - PubMed
-
- Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, Walton S, Kerrouche N, Thomas G, Soto P, AKtion Investigators Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryo-therapy in subjects with actinic keratoses: A multicentre, randomized controlled study. Br J Dermatol. 2006;1:66–71. - PubMed
-
- Steinbauer JM, Schremi S, Babilas P, Zeman F, Karrer S, Landthaler M, Szeimies RM. Topical photodynamic therapy with porphyrin precursors-assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci. 2009;8:1111–1116. - PubMed
-
- Grapengiesser S, Gudmundsson F, Larkö O, Ericson M, Rosén A, Wennberg A-M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497. - PubMed
-
- He J, Larkin HE, Li Y, Rihter BS, Zaidi S, Rodgers M, Mukhtar H, Kenney ME, Oleinick NL. The synthesis, photophysical and photobiological properties and in vitro structure—Activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol. 1997;65:581–586. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials